United Lithium Corp.
United Lithium Corp. (ULTHF) Financial Performance & Income Statement Overview
Explore the financials of United Lithium Corp. (ULTHF), including yearly and quarterly data on income, cash flow, and balance sheets.
United Lithium Corp. (ULTHF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for United Lithium Corp. ULTHF financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Cost of Revenue | $16348.00 | $17661.00 | $15911.00 | $16347.00 |
Gross Profit | -$16348.00 | -$17661.00 | -$15911.00 | -$16347.00 |
Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $166409.00 | $376133.00 | $346768.00 | $708571.00 |
Operating Expenses | $180128.00 | $3.67M | -$423362.00 | $708571.00 |
Total Costs & Expenses | $196476.00 | $3.69M | -$407451.00 | $724918.00 |
Interest Income | $14367.00 | $24436.00 | $0.00 | $55616.00 |
Interest Expense | $5320.00 | $5763.00 | $19577.00 | $6588.00 |
Depreciation & Amortization | $16348.00 | $17661.00 | $15036.00 | $16347.00 |
EBITDA | -$171721.00 | -$700391.00 | -$334095.00 | -$649035.00 |
EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | -$196476.00 | -$3.69M | -$399760.00 | -$724920.00 |
Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
Other Income/Expenses (Net) | $3087.00 | $2.96M | $43572.00 | $52311.00 |
Income Before Tax | -$193389.00 | -$723815.00 | -$356188.00 | -$671967.00 |
Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $3966.00 |
Net Income | -$193389.00 | -$723815.00 | -$356188.00 | -$675930.00 |
Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
EPS | $0.00 | $0.00 | -$0.008 | -$0.02 |
Diluted EPS | $0.00 | $0.00 | -$0.008 | -$0.02 |
Weighted Avg Shares Outstanding | $47.74M | $0.00 | $42.26M | $35.64M |
Weighted Avg Shares Outstanding (Diluted) | $47.74M | $0.00 | $42.26M | $35.64M |
The company's financials show resilient growth, with revenue advancing from $0.00 in Q2 2024 to $0.00 in Q1 2025. Gross profit remained healthy with margins at N/A in Q1 2025 compared to N/A in Q2 2024. Operating income hit -$196476.00 last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$171721.00. Net income rose to -$193389.00, while earnings per share reached $0.00. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan